0031-8719 NDC - ROBITUSSIN MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM (DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN)

Drug Information

Product NDC: 0031-8719

Proprietary Name: Robitussin Maximum Strength Cough Plus Chest Congestion DM

Non Proprietary Name: dextromethorphan hydrobromide and guaifenesin

Active Ingredient(s):
  • 10 mg/1 DEXTROMETHORPHAN HYDROBROMIDE;
  • 200 mg/1 GUAIFENESIN


Administration Route(s): ORAL

Dosage Form(s): CAPSULE, LIQUID FILLED

Labeler Information

Labeler Name: Richmond Division of Wyeth
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date:5/23/2013

Package Information

No. Package Code Package Description Billing Unit
10031-8719-105 BLISTER PACK in 1 CARTON (0031-8719-10) > 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
20031-8719-2010 BLISTER PACK in 1 CARTON (0031-8719-20) > 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACKEA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0031-8719The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMERobitussin Maximum Strength Cough Plus Chest Congestion DMThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEdextromethorphan hydrobromide and guaifenesinThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULE, LIQUID FILLEDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/23/2013This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart341This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMERichmond Division of WyethName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEDEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH10; 200 
ACTIVE INGRED UNITmg/1; mg/1 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 7/15/2019